doi:10.1038/s42255-020-00327-x [2] Zhao X, Wang M, Wen Z, Lu Z, Cui L, Fu C, Xue H, Liu Y, Zhang Y
Similarly, semaglutide ameliorates doxorubicin-induced cardiotoxicity by reducing BNIP3-mediated mitochondrial dysfunction through the PI3K/AKT pathway, enhancing mitochondrial function and reducing cardiac injury (Li et al., 2024), potentiating its clinical application in cardiovascular diseases
This timing recommendation is based on the medication's short-acting profile and its mechanism of slowing gastric emptying, which is most beneficial when timed with food intake
A practical framework is to separate baseline, follow-up, and symptom-triggered testing
comparison Amylin research adjacent to incretin and glucagon literature